In 1984 the Journal became the first of the major medical journalsto require authors of original research articles to discloseany financial ties with companies that make products discussedin papers submitted to us.1 We were aware that such ties werebecoming fairly common, and we thought it reasonable to disclosethem to readers. Although we came to this issue early, no onecould have foreseen at the time just how ubiquitous and manifoldsuch financial associations would become. The article by Kelleret al.2 in this issue of the Journal provides a striking example.The authors' ties with . . . [Full Text of this Article]
References
Related Letters:
Is Academic Medicine for Sale?
Ross L. F., Norton J. W., Young S. A., Lebowitz J., Leong G. B., Silva J. A., Dillon D. C., Jagger J., Firlik A. D., Lowry D. W., Diamond C., Ruane T. J., Hagan B. M., Miller P. D., Angell M.
Extract |
Full Text
N Engl J Med 2000;
343:508-510, Aug 17, 2000.
Correspondence
This article has been cited by other articles:
Liesegang, T. J.
(2008). Commercialism, Loss of Professionalism, and the Effect on Journals. Arch Ophthalmol
126: 1292-1295
[Full Text]
McClelland, S. I., Fine, M.
(2008). Embedded Science: Critical Analysis of Abstinence-Only Evaluation Research. Cultural Studies <=> Critical Methodologies
8: 50-81
[Abstract]
Hartley, H., Coleman, C.-L.
(2008). News media coverage of direct-to-consumer pharmaceutical advertising: implications for countervailing powers theory. Health (London)
12: 107-132
[Abstract]
Steinman, M. A., Baron, R. B.
(2007). Is continuing medical education a drug-promotion tool?: YES. cfp
53: 1650-1653
[Full Text]
Steinman, M. A., Baron, R. B.
(2007). La formation medicale continue est-elle un outil de promotion pharmaceutique?: OUI. cfp
53: 1654-1657
[Full Text]
Parascandola, M.
(2007). A Turning Point for Conflicts of Interest: The Controversy Over the National Academy of Sciences' First Conflicts of Interest Disclosure Policy. JCO
25: 3774-3779
[Abstract][Full Text]
Epstein, M.
(2007). Legal and institutional fictions in medical ethics: a common, and yet largely overlooked, phenomenon. J. Med. Ethics
33: 362-364
[Full Text]
Okike, K., Kocher, M. S.
(2007). The Legal and Ethical Issues Surrounding Financial Conflict of Interest in Orthopaedic Research. JBJS
89: 910-913
[Full Text]
Loscalzo, J.
(2007). Entrepreneurship in the Medical Academy: Possibilities and Challenges in Commercialization of Research Discoveries. Circulation
115: 1504-1507
[Full Text]
Campbell, E. G., Weissman, J. S., Vogeli, C., Clarridge, B. R., Abraham, M., Marder, J. E., Koski, G.
(2006). Financial Relationships between Institutional Review Board Members and Industry. NEJM
355: 2321-2329
[Abstract][Full Text]
Weinfurt, K. P., Friedman, J. Y., Dinan, M. A., Allsbrook, J. S., Hall, M. A., Dhillon, J. K., Sugarman, J.
(2006). Disclosing Conflicts of Interest in Clinical Research: Views of Institutional Review Boards, Conflict of Interest Committees, and Investigators. J Law Med Ethics
34: 581-591
Mintzberg, H.
(2006). Patent nonsense: Evidence tells of an industry out of social control.. CMAJ
175: 374-374
[Full Text]
Hartley, H.
(2006). The 'Pinking' of Viagra Culture: Drug Industry Efforts to Create and Repackage Sex Drugs for Women. Sexualities
9: 363-378
[Abstract]
Jacobs, J. J., Galante, J. O., Mirza, S. K., Zdeblick, T.
(2006). Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?. JBJS
88: 1650-1663
[Full Text]
Genuis, S J
(2006). Dismembering the ethical physician.. Postgrad. Med. J.
82: 233-238
[Abstract][Full Text]
Taylor, W. C.
(2006). A 71-Year-Old Woman Contemplating a Screening Colonoscopy. JAMA
295: 1161-1167
[Full Text]
Henry, D., Doran, E., Kerridge, I., Hill, S., McNeill, P. M., Day, R.
(2005). Ties That Bind: Multiple Relationships Between Clinical Researchers and the Pharmaceutical Industry. Arch Intern Med
165: 2493-2496
[Abstract][Full Text]
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., Nierenberg, A. A.
(2005). Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry. Am. J. Psychiatry
162: 1957-1960
[Abstract][Full Text]
Stossel, T. P.
(2005). Regulating Academic-Industrial Research Relationships -- Solving Problems or Stifling Progress?. NEJM
353: 1060-1065
[Full Text]
Genuis, S. J.
(2005). The Proliferation of Clinical Practice Guidelines: Professional Development or Medicine-by-Numbers?. J Am Board Fam Med
18: 419-425
[Abstract][Full Text]
Haack, S.
(2005). Trial and Error: The Supreme Court's Philosophy of Science. Am. J. Public Health
95: S66-S73
[Abstract][Full Text]
Mohl, P. C.
(2005). Psychiatric Training Program Engagement With the Pharmaceutical Industry: An Educational Issue, Not Strictly an Ethical One. Acad. Psychiatry
29: 215-221
[Abstract][Full Text]
Brodkey, A. C.
(2005). The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem. Acad. Psychiatry
29: 222-229
[Abstract][Full Text]
Benos, D. J., Fabres, J., Farmer, J., Gutierrez, J. P., Hennessy, K., Kosek, D., Lee, J. H., Olteanu, D., Russell, T., Shaikh, F., Wang, K.
(2005). Ethics and scientific publication. Adv. Physiol. Educ.
29: 59-74
[Abstract][Full Text]
Curtis, P., Gaylord, S.
(2005). Safety Issues in the Interaction of Conventional, Complementary, and Alternative Health Care. Complementary Health Practice Review
10: 3-31
[Abstract]
Ferris, L. E., Naylor, C. D.
(2004). Rebuttal. CMAJ
171: 892-893
[Full Text]
(2004). Correction. Am. J. Psychiatry
161: 1145-1145
[Full Text]
CARROLL, B. J.
(2004). Correction. Am. J. Psychiatry
161: 1145-1146
[Full Text]
Helft, P. R., Ratain, M. J., Epstein, R. A., Siegler, M.
(2004). Inside Information: Financial Conflicts of Interest for Research Subjects in Early Phase Clinical Trials. JNCI J Natl Cancer Inst
96: 656-661
[Abstract][Full Text]
Packer, S., Parke, D. W. II
(2004). Ethical Concerns in Industry Support of Continuing Medical Education: The Con Side. Arch Ophthalmol
122: 773-776
[Full Text]
CARROLL, B. J.
(2004). Sertraline and the Cheshire Cat in Geriatric Depression. Am. J. Psychiatry
161: 759-759
[Full Text]
DuVal, G
(2004). Institutional ethics review of clinical study agreements. J. Med. Ethics
30: 30-34
[Abstract][Full Text]
Kim, S Y H, Millard, R W, Nisbet, P, Cox, C, Caine, E D
(2004). Potential research participants' views regarding researcher and institutional financial conflicts of interest. J. Med. Ethics
30: 73-79
[Abstract][Full Text]
Sharav, V. H.
(2004). Conflicts of Interest in Biomedical Research Harm Children With and Without Disabilities. Journal of Disability Policy Studies
15: 50-59
[Abstract]
Rosen, G. M., Davison, G. C.
(2003). Psychology Should List Empirically Supported Principles of Change (ESPs) and Not Credential Trademarked Therapies or Other Treatment Packages. Behav Modif
27: 300-312
[Abstract]
Egilman, D. S., Ehrle, L. H.
(2003). Handling Conflicts of Interest Between Industry and Academia. JAMA
289: 3240-3240
[Full Text]
Bruce Fye, W.
(2003). The power of clinical trials and guidelines,and the challenge of conflicts of interest. J Am Coll Cardiol
41: 1237-1242
[Full Text]
Johns, M. M. E., Barnes, M., Florencio, P. S.
(2003). Restoring Balance to Industry-Academia Relationships in an Era of Institutional Financial Conflicts of Interest: Promoting Research While Maintaining Trust. JAMA
289: 741-746
[Abstract][Full Text]
Hafferty, F.
(2003). Finding Soul in a "Medical Profession of One". Journal of Health Politics, Policy and Law
28: 133-158
Barnes, M., Florencio, P. S.
(2002). Financial Conflicts of Interest in Human Subjects Research: The Problem of Institutional Conflicts. J Law Med Ethics
30: 390-402
Kennedy, H. L., Rosenson, R. S.
(2002). Physicians' interpretation of "class effects": A need for thoughtful re-evaluation. J Am Coll Cardiol
40: 19-26
[Abstract][Full Text]
Levine, M. M, Campbell, J. D, Kotloff, K. L
(2002). Overview of vaccines and immunisation. Br Med Bull
62: 1-13
[Full Text]
(2002). Scientific Data from Clinical Trials: Investigators' Responsibilities and Rights. Ann. Surg. Oncol.
9: 421-422
[Full Text]
(2002). Scientific Data From Clinical Trials: Investigators' Responsibilities and Rights. Arch Surg
137: 639-640
[Full Text]
van Beinum, M., Thomas, P., Faulkner, A.
(2002). User-led research and evidence in psychiatry * Authors' reply. Br. J. Psychiatry
180: 549-550
[Full Text]
Steinbrook, R.
(2002). Improving Protection for Research Subjects. NEJM
346: 1425-1430
[Full Text]
Rees, J.
(2002). Complex Disease and the New Clinical Sciences. Science
296: 698-700
[Abstract][Full Text]
Alpert, J. S., Furman, S., Smaha, L.
(2002). Conflicts of Interest: Science, Money, and Health. Arch Intern Med
162: 635-637
[Full Text]
Lenzer, J., Warlow, C., Saver, J. L, Kidwell, C. S, Starkman, S.
(2002). Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign * Commentary: Who pays the guideline writers? * Commentary: Thrombolysis in stroke: it works!. BMJ
324: 723-729
[Full Text]
Coyle, S. L., for the Ethics and Human Rights Committee, America,
(2002). Physician-Industry Relations. Part 1: Individual Physicians. ANN INTERN MED
136: 396-402
[Abstract][Full Text]
Carpenter, W. T. Jr
(2002). From Clinical Trial to Prescription. Arch Gen Psychiatry
59: 282-285
[Abstract][Full Text]
Gelijns, A. C., Thier, S. O.
(2002). Medical Innovation and Institutional Interdependence: Rethinking University-Industry Connections. JAMA
287: 72-77
[Abstract][Full Text]
Morin, K., Rakatansky, H., Riddick, F. A. Jr, Morse, L. J., O'Bannon III, J. M., Goldrich, M. S., Ray, P., Weiss, M., Sade, R. M., Spillman, M. A.
(2002). Managing Conflicts of Interest in the Conduct of Clinical Trials. JAMA
287: 78-84
[Abstract][Full Text]
Kalb, P. E., Koehler, K. G.
(2002). Legal Issues in Scientific Research. JAMA
287: 85-91
[Abstract][Full Text]
Markowitz, G., Rosner, D.
(2002). Corporate Responsibility for Toxins. The ANNALS of the American Academy of Political and Social Science
584: 159-174
[Abstract]
Tompkins, R. K., Ko, C. Y., Donovan, A. J.
(2001). Internationalization of General Surgical Journals: Origin and Content of Articles Published in North America and Great Britain From 1983 to 1998. Arch Surg
136: 1345-1351
[Abstract][Full Text]
Abzug, M. J., Esterl, E. A.
(2001). Establishment of a Clinical Trials Office at a Children's Hospital. Pediatrics
108: 1129-1134
[Abstract][Full Text]
Ryden, L., Simoons, M.L., Bassand, J.P.
(2001). Partnership in cardiovascular medicine. A key to success not only for professional organizations. Eur Heart J
22: 1839-1843
Smith, R.
(2001). Maintaining the integrity of the scientific record. BMJ
323: 588-588
[Full Text]
DeAngelis, C. D., Fontanarosa, P. B., Flanagin, A.
(2001). Reporting Financial Conflicts of Interest and Relationships Between Investigators and Research Sponsors. JAMA
286: 89-91
[Full Text]
Hergott, L. J.
(2001). Lost in a Dark Wood: How Wisdom Sources Can Light the Way. JAMA
285: 1938-1939
[Full Text]
Jones, T. C
(2001). Call for a new approach to the process of clinical trials and drug registration. BMJ
322: 920-923
[Full Text]
Moses III, H., Martin, J. B.
(2001). Academic Relationships With Industry: A New Model for Biomedical Research. JAMA
285: 933-935
[Full Text]
Lurie, S. J.
(2001). JAMA 2001 Medical Education Issue: A Call for Papers. JAMA
285: 465-466
[Full Text]
Drueke, T. B., Lameire, N.
(2001). Report from the Editorial Office. Nephrol Dial Transplant
16: 29-31
[Full Text]
Lo, B., Wolf, L. E., Berkeley, A.
(2000). Conflict-of-Interest Policies for Investigators in Clinical Trials. NEJM
343: 1616-1620
[Abstract][Full Text]
McCrary, S. V., Anderson, C. B., Jakovljevic, J., Khan, T., McCullough, L. B., Wray, N. P., Brody, B. A.
(2000). A National Survey of Policies on Disclosure of Conflicts of Interest in Biomedical Research. NEJM
343: 1621-1626
[Abstract][Full Text]
Martin, J. B., Kasper, D. L.
(2000). In Whose Best Interest? Breaching the Academic-Industrial Wall. NEJM
343: 1646-1649
[Full Text]
Boyd, E. A., Bero, L. A.
(2000). Assessing Faculty Financial Relationships With Industry: A Case Study. JAMA
284: 2209-2214
[Abstract][Full Text]
Korn, D.
(2000). Conflicts of Interest in Biomedical Research. JAMA
284: 2234-2237
[Full Text]
Shalala, D.
(2000). Protecting Research Subjects -- What Must Be Done. NEJM
343: 808-810
[Full Text]
McRae, S., Hamilton, R.
(2000). Research ethics and a patient in her 70s. CMAJ
163: 495-495
[Full Text]
Ross, L. F., Norton, J. W., Young, S. A., Lebowitz, J., Leong, G. B., Silva, J. A., Dillon, D. C., Jagger, J., Firlik, A. D., Lowry, D. W., Diamond, C., Ruane, T. J., Hagan, B. M., Miller, P. D., Angell, M.
(2000). Is Academic Medicine for Sale?. NEJM
343: 508-510
[Full Text]
Previous
